{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:11:14Z","timestamp":1788851474466,"version":"build-2803163510"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Meningioma biology has been substantially clarified by recent omics-based studies, which have identified recurrent mutations, copy-number alterations, and distinct molecular subgroups. However, although these approaches have provided a valuable framework, they are inherently limited in their ability to establish direct causal relationships. The mechanistic studies are therefore indispensable for translating these molecular observations into biological understanding. Nevertheless, the mechanistic literature has often evolved in a fragmented manner, with individual pathways and model systems studied in relative isolation from the broader multi-omic landscape. In this review, we synthesize these complementary bodies of work into an integrated framework and outline a clear roadmap for future studies. We first review the historical development of established meningioma cell lines, their current molecular characterization, and the recent emergence of 3D models and organoids. Intrinsic challenges in modeling meningioma in vitro are discussed, including the difficulty of establishing immortalized cell lines from predominantly benign tumors, genetic alterations introduced during immortalization, and drift under culture conditions that differ substantially from those of the parental tumors. Next, insights from functional studies centered on these models are integrated within the molecular framework established by large-scale omics analyses. To avoid fragmentation and overemphasis on isolated findings, prior studies are organized into six categories based on major signaling pathways: Hippo, PI3K\/Akt\/mTOR, MAPK, Wnt\/\u03b2-catenin, FOXM1, and Notch. Finally, lessons from other cancer models, including experimental approaches to chromosome-scale genomic disturbances, are considered to provide a more integrated view of meningioma biology and to highlight directions for future research.<\/jats:p>","DOI":"10.1007\/s13577-026-01448-3","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:02:03Z","timestamp":1788847323000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modeling meningioma in vitro in the omics era"],"prefix":"10.1007","volume":"39","author":[{"given":"Daisuke","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-3391","authenticated-orcid":false,"given":"Satoru","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Teranishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhito","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"issue":"3","key":"1448_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","volume":"99","author":"J Wiemels","year":"2010","unstructured":"Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99(3):307\u201314.","journal-title":"J Neurooncol"},{"issue":"12 Suppl 2","key":"1448_CR2","first-page":"iv1","volume":"25","author":"QT Ostrom","year":"2016","unstructured":"Ostrom QT, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020. Neuro Oncol. 2016;25(12 Suppl 2):iv1\u201399.","journal-title":"Neuro Oncol"},{"issue":"8","key":"1448_CR3","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231\u201351.","journal-title":"Neuro Oncol"},{"issue":"6123","key":"1448_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013;339(6123):1077\u201380.","journal-title":"Science"},{"issue":"3","key":"1448_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ng.2526","volume":"45","author":"PK Brastianos","year":"2013","unstructured":"Brastianos PK, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet. 2013;45(3):285\u20139.","journal-title":"Nat Genet"},{"issue":"5","key":"1448_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/neuonc\/nov316","volume":"18","author":"M Abedalthagafi","year":"2016","unstructured":"Abedalthagafi M, et al. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol. 2016;18(5):649\u201355.","journal-title":"Neuro Oncol"},{"issue":"10","key":"1448_CR7","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ng.3651","volume":"48","author":"VE Clark","year":"2016","unstructured":"Clark VE, et al. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet. 2016;48(10):1253\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"1448_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00401-023-02571-3","volume":"146","author":"JZ Wang","year":"2023","unstructured":"Wang JZ, et al. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. Acta Neuropathol. 2023;146(1):145\u201362.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1448_CR9","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S1470-2045(25)00422-X","volume":"26","author":"KJ Groff","year":"2025","unstructured":"Groff KJ, et al. The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysis. Lancet Oncol. 2025;26(9):1178\u201390.","journal-title":"Lancet Oncol"},{"issue":"9","key":"1448_CR10","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1093\/neuonc\/noaf105","volume":"27","author":"P Sievers","year":"2025","unstructured":"Sievers P, et al. Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of polycomb repressive complex target genes. Neuro Oncol. 2025;27(9):2326\u201340.","journal-title":"Neuro Oncol"},{"key":"1448_CR11","doi-asserted-by":"crossref","unstructured":"Parrish AG, et al. PTEN deficiency linked to chromosome 10q loss leads to aggressive NF2 mutant meningioma biology. bioRxiv; 2025.","DOI":"10.64898\/2025.12.21.695820"},{"issue":"5","key":"1448_CR12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/neuonc\/noab213","volume":"24","author":"J Driver","year":"2022","unstructured":"Driver J, et al. A molecularly integrated grade for meningioma. Neuro Oncol. 2022;24(5):796\u2013808.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1448_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s40478-025-02149-y","volume":"13","author":"K Ohara","year":"2025","unstructured":"Ohara K, et al. Sequential omics analysis reveals molecular signatures of malignant transformation in recurrent meningiomas. Acta Neuropathol Commun. 2025;13(1):235.","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"1448_CR14","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1093\/neuonc\/noab036","volume":"23","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, et al. Loss of H3K27me3 in meningiomas. Neuro Oncol. 2021;23(8):1282\u201391.","journal-title":"Neuro Oncol"},{"key":"1448_CR15","doi-asserted-by":"publisher","first-page":"14433","DOI":"10.1038\/ncomms14433","volume":"8","author":"AS Harmanci","year":"2017","unstructured":"Harmanci AS, et al. Integrated genomic analyses of de novo pathways underlying atypical meningiomas. Nat Commun. 2017;8:14433.","journal-title":"Nat Commun"},{"issue":"13","key":"1448_CR16","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","volume":"22","author":"HN Vasudevan","year":"2018","unstructured":"Vasudevan HN, et al. Comprehensive molecular profiling identifies FOXM1 as a key transcription factor for meningioma proliferation. Cell Rep. 2018;22(13):3672\u201383.","journal-title":"Cell Rep"},{"issue":"2","key":"1448_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/nan.12571","volume":"46","author":"H Kim","year":"2020","unstructured":"Kim H, et al. Forkhead box M1 (FOXM1) transcription factor is a key oncogenic driver of aggressive human meningioma progression. Neuropathol Appl Neurobiol. 2020;46(2):125\u201341.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"1448_CR18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","volume":"54","author":"A Choudhury","year":"2022","unstructured":"Choudhury A, et al. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet. 2022;54(5):649\u201359.","journal-title":"Nat Genet"},{"issue":"7874","key":"1448_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","volume":"597","author":"F Nassiri","year":"2021","unstructured":"Nassiri F, et al. A clinically applicable integrative molecular classification of meningiomas. Nature. 2021;597(7874):119\u201325.","journal-title":"Nature"},{"key":"1448_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2025.0329","author":"AP Landry","year":"2025","unstructured":"Landry AP, et al. Chromosome 1p loss and 1q gain for grading of meningioma. JAMA Oncol. 2025. https:\/\/doi.org\/10.1001\/jamaoncol.2025.0329.","journal-title":"JAMA Oncol"},{"issue":"2","key":"1448_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/neuonc\/noae170","volume":"27","author":"F Sahm","year":"2025","unstructured":"Sahm F, et al. cIMPACT-NOW update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas. Neuro Oncol. 2025;27(2):319\u201330.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1448_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s40478-025-02083-z","volume":"13","author":"Y Hirano","year":"2025","unstructured":"Hirano Y, et al. Integrated molecular and detailed anatomical profiling identifies a prognostically adverse subtype of posterior fossa meningiomas: high-risk copy number alterations are associated with midline predilection and predict poor prognosis. Acta Neuropathol Commun. 2025;13(1):168.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1448_CR23","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s40478-025-02153-2","volume":"13","author":"M Umekawa","year":"2025","unstructured":"Umekawa M, et al. Molecular insights into prognostic model for meningiomas treated with stereotactic radiosurgery: negative impacts of 1q gain on tumor control and survival. Acta Neuropathol Commun. 2025;13(1):232.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1448_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s40478-025-02111-y","volume":"13","author":"Y Hirano","year":"2025","unstructured":"Hirano Y, et al. Two molecular subtypes of skull base meningiomas with extracranial extension. Acta Neuropathol Commun. 2025;13(1):201.","journal-title":"Acta Neuropathol Commun"},{"key":"1448_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133183","author":"Y Sakai","year":"2022","unstructured":"Sakai Y, et al. NF2 alteration\/22q loss is associated with recurrence in WHO grade 1 sphenoid wing meningiomas. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14133183.","journal-title":"Cancers (Basel)"},{"issue":"3-4","key":"1448_CR26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000056986","volume":"93","author":"KD Zang","year":"2001","unstructured":"Zang KD. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet. 2001;93(3\u20134):207\u201320.","journal-title":"Cytogenet Cell Genet"},{"issue":"1","key":"1448_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86298-9","volume":"11","author":"A Okano","year":"2021","unstructured":"Okano A, et al. Associations of pathological diagnosis and genetic abnormalities in meningiomas with the embryological origins of the meninges. Sci Rep. 2021;11(1):6987.","journal-title":"Sci Rep"},{"issue":"2","key":"1448_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1227\/neu.0000000000002873","volume":"95","author":"A Okano","year":"2024","unstructured":"Okano A, et al. POLR2A mutation is a poor prognostic marker of cerebellopontine angle meningioma. Neurosurgery. 2024;95(2):275\u201383.","journal-title":"Neurosurgery"},{"issue":"1","key":"1448_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s40478-024-01835-7","volume":"12","author":"Y Hirano","year":"2024","unstructured":"Hirano Y, et al. Genetic analysis of foramen magnum meningiomas reveals AKT1 mutations uncomplicated by TRAF7 mutations. Acta Neuropathol Commun. 2024;12(1):123.","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"1448_CR30","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3171\/2019.8.JNS191266","volume":"133","author":"MW Youngblood","year":"2020","unstructured":"Youngblood MW, et al. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg. 2020;133(5):1345\u201354.","journal-title":"J Neurosurg"},{"issue":"5","key":"1448_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/neuonc\/noaa226","volume":"23","author":"MW Youngblood","year":"2021","unstructured":"Youngblood MW, et al. Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol. 2021;23(5):783\u201394.","journal-title":"Neuro Oncol"},{"issue":"5","key":"1448_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","volume":"18","author":"F Sahm","year":"2017","unstructured":"Sahm F, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017;18(5):682\u201394.","journal-title":"Lancet Oncol"},{"issue":"5","key":"1448_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm6247","volume":"8","author":"JCt Bayley","year":"2022","unstructured":"Bayley JCt, et al. Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies. Sci Adv. 2022;8(5):eabm6247.","journal-title":"Sci Adv"},{"issue":"2","key":"1448_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41588-025-02475-w","volume":"58","author":"SLN Maas","year":"2026","unstructured":"Maas SLN, et al. A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification. Nat Genet. 2026;58(2):341\u201354.","journal-title":"Nat Genet"},{"issue":"1","key":"1448_CR35","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.1038\/s41467-020-18582-7","volume":"11","author":"ST Magill","year":"2020","unstructured":"Magill ST, et al. Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma. Nat Commun. 2020;11(1):4803.","journal-title":"Nat Commun"},{"issue":"16","key":"1448_CR36","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1158\/0008-5472.CAN-20-3669","volume":"81","author":"P Najm","year":"2021","unstructured":"Najm P, et al. Loss-of-function mutations in TRAF7 and KLF4 cooperatively activate RAS-like GTPase signaling and promote meningioma development. Cancer Res. 2021;81(16):4218\u201329.","journal-title":"Cancer Res"},{"issue":"1","key":"1448_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40478-020-00994-7","volume":"8","author":"S Findakly","year":"2020","unstructured":"Findakly S, et al. Meningioma cells express primary cilia but do not transduce ciliary Hedgehog signals. Acta Neuropathol Commun. 2020;8(1):114.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1448_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac162","volume":"4","author":"MP Nguyen","year":"2022","unstructured":"Nguyen MP, et al. A case (report) for mechanistic validation of meningioma molecular therapies. Neuro-Oncol Adv. 2022;4(1):vdac162.","journal-title":"Neuro-Oncol Adv"},{"issue":"11","key":"1448_CR39","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1056\/NEJMoa2100440","volume":"385","author":"M Peyre","year":"2021","unstructured":"Peyre M, et al. Somatic PIK3CA mutations in sporadic cerebral cavernous malformations. N Engl J Med. 2021;385(11):996\u20131004.","journal-title":"N Engl J Med"},{"issue":"9","key":"1448_CR40","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1101\/gad.226302","volume":"16","author":"M Kalamarides","year":"2002","unstructured":"Kalamarides M, et al. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev. 2002;16(9):1060\u20135.","journal-title":"Genes Dev"},{"issue":"32","key":"1448_CR41","doi-asserted-by":"publisher","first-page":"32713","DOI":"10.18632\/oncotarget.5296","volume":"6","author":"M Peyre","year":"2015","unstructured":"Peyre M, et al. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Oncotarget. 2015;6(32):32713\u201322.","journal-title":"Oncotarget"},{"issue":"10","key":"1448_CR42","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1158\/2159-8290.CD-23-1459","volume":"14","author":"A Choudhury","year":"2024","unstructured":"Choudhury A, et al. Perivascular NOTCH3+ stem cells drive meningioma tumorigenesis and resistance to radiotherapy. Cancer Discov. 2024;14(10):1823\u201337.","journal-title":"Cancer Discov"},{"issue":"1","key":"1448_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52284-8","volume":"15","author":"CD Eaton","year":"2024","unstructured":"Eaton CD, et al. Merlin(S13) phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging features. Nat Commun. 2024;15(1):7873.","journal-title":"Nat Commun"},{"key":"1448_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-69296-1","author":"MW Youngblood","year":"2026","unstructured":"Youngblood MW, et al. STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways. Nat Commun. 2026. https:\/\/doi.org\/10.1038\/s41467-026-69296-1.","journal-title":"Nat Commun"},{"issue":"6","key":"1448_CR45","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41588-024-01747-1","volume":"56","author":"CG Lucas","year":"2024","unstructured":"Lucas CG, et al. Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution. Nat Genet. 2024;56(6):1121\u201333.","journal-title":"Nat Genet"},{"issue":"1","key":"1448_CR46","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1186\/s12967-023-04620-7","volume":"21","author":"MS Andersen","year":"2023","unstructured":"Andersen MS, et al. Meningioma animal models: a systematic review and meta-analysis. J Transl Med. 2023;21(1):764.","journal-title":"J Transl Med"},{"issue":"5","key":"1448_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178322","volume":"12","author":"Y Mei","year":"2017","unstructured":"Mei Y, et al. Genomic profile of human meningioma cell lines. PLoS ONE. 2017;12(5):e0178322.","journal-title":"PLoS ONE"},{"issue":"3","key":"1448_CR48","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1227\/00006123-199009000-00008","volume":"27","author":"WH Lee","year":"1990","unstructured":"Lee WH. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery. 1990;27(3):389\u201395.","journal-title":"Neurosurgery."},{"issue":"11","key":"1448_CR49","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/neuonc\/noab150","volume":"23","author":"R Goldbrunner","year":"2021","unstructured":"Goldbrunner R, et al. EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021;23(11):1821\u201334.","journal-title":"Neuro Oncol"},{"key":"1448_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.70078","author":"D Sato","year":"2026","unstructured":"Sato D, et al. Optic nerve sheath meningioma exhibits neural niche-associated transcriptomic features and rare copy number variation-linked evolution. Brain Pathol. 2026. https:\/\/doi.org\/10.1111\/bpa.70078.","journal-title":"Brain Pathol"},{"issue":"4","key":"1448_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nrc775","volume":"2","author":"JR Masters","year":"2002","unstructured":"Masters JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer. 2002;2(4):315\u20139.","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"1448_CR52","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1073\/pnas.121616198","volume":"98","author":"JR Masters","year":"2001","unstructured":"Masters JR, et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A. 2001;98(14):8012\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1448_CR53","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.semcancer.2011.10.001","volume":"21","author":"JW Shay","year":"2011","unstructured":"Shay JW, Wright WE. Role of telomeres and telomerase in cancer. Semin Cancer Biol. 2011;21(6):349\u201353.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"1448_CR54","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1002\/1097-0142(19891201)64:11<2243::AID-CNCR2820641110>3.0.CO;2-S","volume":"64","author":"K Tanaka","year":"1989","unstructured":"Tanaka K, et al. Establishment of a human malignant meningioma cell line with amplified c-myc oncogene. Cancer. 1989;64(11):2243\u20139.","journal-title":"Cancer"},{"key":"1448_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184448","author":"G Mondielli","year":"2022","unstructured":"Mondielli G, et al. Co-targeting MAP kinase and Pi3K-Akt-mTOR pathways in meningioma: preclinical study of alpelisib and trametinib. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14184448.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"1448_CR56","doi-asserted-by":"publisher","first-page":"864","DOI":"10.3171\/jns.1995.82.5.0864","volume":"82","author":"JC Tsai","year":"1995","unstructured":"Tsai JC, Goldman CK, Gillespie GY. Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg. 1995;82(5):864\u201373.","journal-title":"J Neurosurg"},{"issue":"6224","key":"1448_CR57","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/339487a0","volume":"339","author":"RJ Hay","year":"1989","unstructured":"Hay RJ, Macy ML, Chen TR. Mycoplasma infection of cultured cells. Nature. 1989;339(6224):487\u20138.","journal-title":"Nature"},{"issue":"2","key":"1448_CR58","first-page":"111","volume":"98","author":"JC Tsai","year":"1999","unstructured":"Tsai JC, et al. Regulation of vascular endothelial growth factor secretion in human meningioma cells. J Formos Med Assoc. 1999;98(2):111\u20137.","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"1448_CR59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.surneu.2007.06.031","volume":"70","author":"BT Ragel","year":"2008","unstructured":"Ragel BT, et al. A comparison of the cell lines used in meningioma research. Surg Neurol. 2008;70(3):295\u2013307.","journal-title":"Surg Neurol"},{"issue":"1","key":"1448_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/A:1006436903976","volume":"49","author":"R Pallini","year":"2000","unstructured":"Pallini R, et al. Phenotypic change of human cultured meningioma cells. J Neurooncol. 2000;49(1):9\u201317.","journal-title":"J Neurooncol"},{"issue":"4","key":"1448_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00401-003-0736-8","volume":"106","author":"K Akat","year":"2003","unstructured":"Akat K, et al. Molecular characterization of desmosomes in meningiomas and arachnoidal tissue. Acta Neuropathol. 2003;106(4):337\u201347.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"1448_CR62","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1749-0774.2004.tb00045.x","volume":"17","author":"I Ishiwata","year":"2004","unstructured":"Ishiwata I, et al. In vitro culture of various typed meningiomas and characterization of a human malignant meningioma cell line (HKBMM). Hum Cell. 2004;17(4):211\u20137.","journal-title":"Hum Cell"},{"issue":"3","key":"1448_CR63","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s11060-025-05219-2","volume":"175","author":"N Naewwan","year":"2025","unstructured":"Naewwan N, et al. Piperlongumine induces meningioma cell death via the ROS-mediated endoplasmic reticulum stress and the alteration of the ubiquitin-proteasome system. J Neurooncol. 2025;175(3):1091\u2013102.","journal-title":"J Neurooncol"},{"key":"1448_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-017-0014-7","author":"WL Bi","year":"2017","unstructured":"Bi WL, et al. Genomic landscape of high-grade meningiomas. npj Genom Med. 2017. https:\/\/doi.org\/10.1038\/s41525-017-0014-7.","journal-title":"npj Genom Med"},{"issue":"1","key":"1448_CR65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/172460080201700105","volume":"17","author":"FM Verheijen","year":"2002","unstructured":"Verheijen FM, et al. TP53 mutations in human meningiomas. Int J Biol Markers. 2002;17(1):42\u20138.","journal-title":"Int J Biol Markers"},{"issue":"9","key":"1448_CR66","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/labinvest.3700307","volume":"85","author":"S Puttmann","year":"2005","unstructured":"Puttmann S, et al. Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest. 2005;85(9):1163\u201371.","journal-title":"Lab Invest"},{"issue":"1","key":"1448_CR67","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10143-024-02571-1","volume":"47","author":"W Khalil","year":"2024","unstructured":"Khalil W, et al. Re-evaluating the grading of established commercialized meningioma cell line. Neurosurg Rev. 2024;47(1):335.","journal-title":"Neurosurg Rev"},{"issue":"4","key":"1448_CR68","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1227\/01.NEU.0000255397.00410.8F","volume":"60","author":"TG Cargioli","year":"2007","unstructured":"Cargioli TG, et al. Establishment of an in vivo meningioma model with human telomerase reverse transcriptase. Neurosurgery. 2007;60(4):750\u20139.","journal-title":"Neurosurgery"},{"issue":"2","key":"1448_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11060-005-9076-y","volume":"78","author":"GS Baia","year":"2006","unstructured":"Baia GS, et al. A genetic strategy to overcome the senescence of primary meningioma cell cultures. J Neurooncol. 2006;78(2):113\u201321.","journal-title":"J Neurooncol"},{"issue":"36","key":"1448_CR70","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1038\/onc.2012.436","volume":"32","author":"M Peyre","year":"2013","unstructured":"Peyre M, et al. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation. Oncogene. 2013;32(36):4264\u201372.","journal-title":"Oncogene"},{"issue":"11","key":"1448_CR71","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.tcb.2019.08.009","volume":"29","author":"JR Cantor","year":"2019","unstructured":"Cantor JR. The rise of physiologic media. Trends Cell Biol. 2019;29(11):854\u201361.","journal-title":"Trends Cell Biol"},{"issue":"9","key":"1448_CR72","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1093\/neuonc\/now031","volume":"18","author":"F Nigim","year":"2016","unstructured":"Nigim F, et al. A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus. Neuro Oncol. 2016;18(9):1278\u201387.","journal-title":"Neuro Oncol"},{"issue":"4","key":"1448_CR73","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11523-019-00654-4","volume":"14","author":"F Nigim","year":"2019","unstructured":"Nigim F, et al. A monoclonal antibody against beta1 integrin inhibits proliferation and increases survival in an orthotopic model of high-grade meningioma. Target Oncol. 2019;14(4):479\u201389.","journal-title":"Target Oncol"},{"key":"1448_CR74","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12967-015-0596-8","volume":"13","author":"SK Michelhaugh","year":"2015","unstructured":"Michelhaugh SK, et al. Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1. J Transl Med. 2015;13:227.","journal-title":"J Transl Med"},{"key":"1448_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040545","author":"G Jungwirth","year":"2019","unstructured":"Jungwirth G, et al. Identification of KIF11 as a novel target in meningioma. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11040545.","journal-title":"Cancers (Basel)"},{"key":"1448_CR76","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12935-020-01438-x","volume":"20","author":"E Kim","year":"2020","unstructured":"Kim E, et al. Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors. Cancer Cell Int. 2020;20:345.","journal-title":"Cancer Cell Int"},{"key":"1448_CR77","doi-asserted-by":"publisher","first-page":"6840271","DOI":"10.1155\/2023\/6840271","volume":"2023","author":"ML Perepechaeva","year":"2023","unstructured":"Perepechaeva ML, Klyushova LS, Grishanova AY. AhR and HIF-1alpha signaling pathways in benign meningioma under hypoxia. Int J Cell Biol. 2023;2023:6840271.","journal-title":"Int J Cell Biol"},{"issue":"3","key":"1448_CR78","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s13577-025-01211-0","volume":"38","author":"T Trasaktaweesakul","year":"2025","unstructured":"Trasaktaweesakul T, et al. In vitro properties of four benign meningioma cells derived from WHO grade 1 meningiomas. Hum Cell. 2025;38(3):84.","journal-title":"Hum Cell"},{"issue":"3","key":"1448_CR79","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s11060-025-05200-z","volume":"175","author":"MZ Sun","year":"2025","unstructured":"Sun MZ, et al. Immunotherapeutic targeting of NY-ESO-1 in malignant meningiomas with TCR-transduced T-cells. J Neurooncol. 2025;175(3):1079\u201389.","journal-title":"J Neurooncol"},{"issue":"1","key":"1448_CR80","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s40478-023-01677-9","volume":"11","author":"LL van de Weijer","year":"2023","unstructured":"van de Weijer LL, et al. A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas. Acta Neuropathol Commun. 2023;11(1):198.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1448_CR81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40478-025-02008-w","volume":"13","author":"MS Andersen","year":"2025","unstructured":"Andersen MS, et al. Establishment of a patient-derived 3D in vitro meningioma model in xeno-free hydrogel for clinical applications. Acta Neuropathol Commun. 2025;13(1):81.","journal-title":"Acta Neuropathol Commun"},{"key":"1448_CR82","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jocn.2021.10.035","volume":"94","author":"HSC Chan","year":"2021","unstructured":"Chan HSC, et al. Establishment and characterization of meningioma patient-derived organoid. J Clin Neurosci. 2021;94:192\u20139.","journal-title":"J Clin Neurosci"},{"issue":"11","key":"1448_CR83","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1093\/neuonc\/noab155","volume":"23","author":"S Yamazaki","year":"2021","unstructured":"Yamazaki S, et al. Newly established patient-derived organoid model of intracranial meningioma. Neuro Oncol. 2021;23(11):1936\u201348.","journal-title":"Neuro Oncol"},{"issue":"1","key":"1448_CR84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12935-024-03225-4","volume":"24","author":"D Kim","year":"2024","unstructured":"Kim D, et al. Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma. Cancer Cell Int. 2024;24(1):36.","journal-title":"Cancer Cell Int"},{"issue":"839","key":"1448_CR85","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aea3115","volume":"18","author":"G Jungwirth","year":"2026","unstructured":"Jungwirth G, et al. Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1\/2i panobinostat. Sci Transl Med. 2026;18(839):eaea3115.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1448_CR86","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s13577-024-01151-1","volume":"38","author":"T Ishikawa","year":"2024","unstructured":"Ishikawa T, et al. Establishment of a novel benign meningioma cell line spontaneously immortalized under hypoxic conditions. Hum Cell. 2024;38(1):22.","journal-title":"Hum Cell"},{"issue":"2","key":"1448_CR87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0294-180","volume":"6","author":"MH Ruttledge","year":"1994","unstructured":"Ruttledge MH, et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet. 1994;6(2):180\u20134.","journal-title":"Nat Genet"},{"issue":"4","key":"1448_CR88","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41580-018-0086-y","volume":"20","author":"IM Moya","year":"2019","unstructured":"Moya IM, Halder G. Hippo-YAP\/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol. 2019;20(4):211\u201326.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"21","key":"1448_CR89","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.cub.2015.08.064","volume":"25","author":"A Keder","year":"2015","unstructured":"Keder A, et al. The hippo pathway core cassette regulates asymmetric cell division. Curr Biol. 2015;25(21):2739\u201350.","journal-title":"Curr Biol"},{"issue":"4","key":"1448_CR90","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13(4):246\u201357.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1448_CR91","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1593\/neo.08642","volume":"10","author":"K Striedinger","year":"2008","unstructured":"Striedinger K, et al. The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Neoplasia. 2008;10(11):1204\u201312.","journal-title":"Neoplasia"},{"issue":"7","key":"1448_CR92","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/NEN.0000000000000211","volume":"74","author":"K Tanahashi","year":"2015","unstructured":"Tanahashi K, et al. Activation of yes-associated protein in low-grade meningiomas is regulated by merlin, cell density, and extracellular matrix stiffness. J Neuropathol Exp Neurol. 2015;74(7):704\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1448_CR93","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1265\/ehpm.24-00216","volume":"30","author":"N Zhang","year":"2025","unstructured":"Zhang N, et al. Lead exposure promotes NF2-wildtype meningioma cell proliferation through the Merlin-Hippo signaling pathway. Environ Health Prev Med. 2025;30:8.","journal-title":"Environ Health Prev Med"},{"issue":"1","key":"1448_CR94","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MAO.0000000000001247","volume":"38","author":"ME Mercado-Pimentel","year":"2017","unstructured":"Mercado-Pimentel ME, et al. Inhibiting p21-activated kinase induces cell death in vestibular schwannoma and meningioma via mitotic catastrophe. Otol Neurotol. 2017;38(1):139\u201346.","journal-title":"Otol Neurotol"},{"issue":"4","key":"1448_CR95","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/brain\/awac342","volume":"146","author":"L Laraba","year":"2023","unstructured":"Laraba L, et al. Inhibition of YAP\/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma. Brain. 2023;146(4):1697\u2013713.","journal-title":"Brain"},{"issue":"1","key":"1448_CR96","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdae148","volume":"6","author":"AG Parrish","year":"2024","unstructured":"Parrish AG, et al. Aggressive high-grade NF2 mutant meningiomas downregulate oncogenic YAP signaling via the upregulation of VGLL4 and FAT3\/4. Neuro-oncol Adv. 2024;6(1):vdae148.","journal-title":"Neuro-oncol Adv"},{"issue":"3","key":"1448_CR97","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrm3290","volume":"13","author":"B Vanhaesebroeck","year":"2012","unstructured":"Vanhaesebroeck B, Stephens L, Hawkins P. PI3K signalling: the path to discovery and understanding. Nat Rev Mol Cell Biol. 2012;13(3):195\u2013203.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1448_CR98","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11060-015-1812-3","volume":"124","author":"T Graillon","year":"2015","unstructured":"Graillon T, et al. Combined treatment by octreotide and everolimus: octreotide enhances inhibitory effect of everolimus in aggressive meningiomas. J Neurooncol. 2015;124(1):33\u201343.","journal-title":"J Neurooncol"},{"issue":"1","key":"1448_CR99","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdae024","volume":"6","author":"S Bhattacharyya","year":"2024","unstructured":"Bhattacharyya S, et al. Preclinical evaluation of the third-generation, bi-steric mechanistic target of rapamycin complex 1-selective inhibitor RMC-6272 in NF2-deficient models. Neuro-oncol Adv. 2024;6(1):vdae024.","journal-title":"Neuro-oncol Adv"},{"issue":"6","key":"1448_CR100","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960\u201376.","journal-title":"Cell"},{"issue":"15","key":"1448_CR101","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1128\/MCB.01581-08","volume":"29","author":"MF James","year":"2009","unstructured":"James MF, et al. NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. Mol Cell Biol. 2009;29(15):4250\u201361.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"1448_CR102","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.3892\/mmr.2015.3805","volume":"12","author":"W Wang","year":"2015","unstructured":"Wang W, et al. Role of HER-2 activity in the regulation of malignant meningioma cell proliferation and motility. Mol Med Rep. 2015;12(3):3575\u201382.","journal-title":"Mol Med Rep"},{"issue":"1","key":"1448_CR103","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12964-017-0189-7","volume":"15","author":"Y Mei","year":"2017","unstructured":"Mei Y, et al. Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling. Cell Commun Signal. 2017;15(1):34.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"1448_CR104","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s12885-024-12084-1","volume":"24","author":"Y Huang","year":"2024","unstructured":"Huang Y, et al. Hsa_circ_0004872 alleviates meningioma progression by sponging miR-190a-3p\/PTEN signaling. BMC Cancer. 2024;24(1):345.","journal-title":"BMC Cancer"},{"key":"1448_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156535","volume":"176","author":"S Singh","year":"2024","unstructured":"Singh S, et al. A gain of function mutation in AKT1 increases hexokinase 2 and diminishes oxidative stress in meningioma. Cytokine. 2024;176:156535.","journal-title":"Cytokine"},{"issue":"2","key":"1448_CR106","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12780","volume":"48","author":"P John","year":"2022","unstructured":"John P, et al. AKT1(E17K)-mutated meningioma cell lines respond to treatment with the AKT inhibitor AZD5363. Neuropathol Appl Neurobiol. 2022;48(2):e12780.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"1448_CR107","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1158\/2767-9764.CRC-25-0563","volume":"6","author":"LS Chang","year":"2026","unstructured":"Chang LS, et al. Combining Brigatinib with mTOR inhibition to effectively treat NF2-SWN-associated and sporadic NF2-deficient meningiomas. Cancer Res Commun. 2026;6(1):211\u201323.","journal-title":"Cancer Res Commun"},{"issue":"10","key":"1448_CR108","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21(10):607\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1448_CR109","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3171\/jns.2001.94.2.0293","volume":"94","author":"MD Johnson","year":"2001","unstructured":"Johnson MD, et al. Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells. J Neurosurg. 2001;94(2):293\u2013300.","journal-title":"J Neurosurg"},{"issue":"4","key":"1448_CR110","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00428-014-1641-3","volume":"465","author":"EA El-Habr","year":"2014","unstructured":"El-Habr EA, et al. Complex interactions between the components of the PI3K\/AKT\/mTOR pathway, and with components of MAPK, JAK\/STAT and Notch-1 pathways, indicate their involvement in meningioma development. Virchows Arch. 2014;465(4):473\u201385.","journal-title":"Virchows Arch"},{"issue":"7","key":"1448_CR111","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252048","volume":"16","author":"LS Chang","year":"2021","unstructured":"Chang LS, et al. Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK. PLoS ONE. 2021;16(7):e0252048.","journal-title":"PLoS ONE"},{"issue":"6","key":"1448_CR112","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/07357907.2020.1773844","volume":"38","author":"A Das","year":"2020","unstructured":"Das A, et al. In vitro effect of dovitinib (TKI258), a multi-target angiokinase inhibitor on aggressive meningioma cells. Cancer Invest. 2020;38(6):349\u201355.","journal-title":"Cancer Invest"},{"issue":"1","key":"1448_CR113","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s12035-016-9763-z","volume":"54","author":"C Jiang","year":"2017","unstructured":"Jiang C, et al. RAS promotes proliferation and resistances to apoptosis in meningioma. Mol Neurobiol. 2017;54(1):779\u201387.","journal-title":"Mol Neurobiol"},{"issue":"36","key":"1448_CR114","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1038\/s41388-019-0883-6","volume":"38","author":"Y Cui","year":"2019","unstructured":"Cui Y, et al. The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling. Oncogene. 2019;38(36):6370\u201381.","journal-title":"Oncogene"},{"issue":"5","key":"1448_CR115","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41580-024-00823-y","volume":"26","author":"MM Maurice","year":"2025","unstructured":"Maurice MM, Angers S. Mechanistic insights into Wnt-beta-catenin pathway activation and signal transduction. Nat Rev Mol Cell Biol. 2025;26(5):371\u201388.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5382","key":"1448_CR116","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"TC He","year":"1998","unstructured":"He TC, et al. Identification of c-MYC as a target of the APC pathway. Science. 1998;281(5382):1509\u201312.","journal-title":"Science"},{"issue":"6726","key":"1448_CR117","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/18884","volume":"398","author":"O Tetsu","year":"1999","unstructured":"Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398(6726):422\u20136.","journal-title":"Nature"},{"issue":"9","key":"1448_CR118","doi-asserted-by":"publisher","first-page":"7027","DOI":"10.1007\/s13277-015-3388-0","volume":"36","author":"A Das","year":"2015","unstructured":"Das A, et al. A novel component from citrus, ginger, and mushroom family exhibits antitumor activity on human meningioma cells through suppressing the Wnt\/beta-catenin signaling pathway. Tumour Biol. 2015;36(9):7027\u201334.","journal-title":"Tumour Biol"},{"issue":"1","key":"1448_CR119","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdz055","volume":"2","author":"J Deng","year":"2020","unstructured":"Deng J, et al. The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations. Neuro-oncol Adv. 2020;2(1):vdz055.","journal-title":"Neuro-oncol Adv"},{"issue":"2","key":"1448_CR120","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.70048","volume":"36","author":"Y Shiraki","year":"2026","unstructured":"Shiraki Y, et al. Meflin\/ISLR is a meningeal cell-specific marker involved in the development of meninges and meningioma progression. Brain Pathol. 2026;36(2):e70048.","journal-title":"Brain Pathol"},{"issue":"2","key":"1448_CR121","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/jcb.29423","volume":"121","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, et al. SNHG1\/miR-556-5p\/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway. J Cell Biochem. 2020;121(2):1880\u20139.","journal-title":"J Cell Biochem"},{"issue":"1","key":"1448_CR122","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00401-024-02788-w","volume":"148","author":"NK Leclair","year":"2024","unstructured":"Leclair NK, et al. The RNA-binding protein IGF2BP1 regulates stability of mRNA transcribed from FOXM1 target genes in hypermitotic meningiomas. Acta Neuropathol. 2024;148(1):28.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"1448_CR123","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.21873\/anticanres.17833","volume":"45","author":"K Nakamura","year":"2025","unstructured":"Nakamura K, et al. Efficient inhibition of FOXM1 expression and viability of high-grade meningioma cells by Domatinostat-mediated dual targeting of HDAC1 and HDAC2. Anticancer Res. 2025;45(11):4853\u201368.","journal-title":"Anticancer Res"},{"issue":"1","key":"1448_CR124","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41420-025-02783-4","volume":"11","author":"L Song","year":"2025","unstructured":"Song L, et al. Identification of SLC7A1 as a potential therapeutic target for high-grade meningioma. Cell Death Discov. 2025;11(1):498.","journal-title":"Cell Death Discov"},{"issue":"7","key":"1448_CR125","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41580-025-00835-2","volume":"26","author":"SJ Bray","year":"2025","unstructured":"Bray SJ, Bigas A. Modes of Notch signalling in development and disease. Nat Rev Mol Cell Biol. 2025;26(7):522\u201337.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"1448_CR126","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1158\/0008-5472.CAN-05-0240","volume":"65","author":"IC Cuevas","year":"2005","unstructured":"Cuevas IC, et al. Meningioma transcript profiles reveal deregulated Notch signaling pathway. Cancer Res. 2005;65(12):5070\u20135.","journal-title":"Cancer Res"},{"issue":"6","key":"1448_CR127","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1593\/neo.08356","volume":"10","author":"GS Baia","year":"2008","unstructured":"Baia GS, et al. Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. Neoplasia. 2008;10(6):604\u201312.","journal-title":"Neoplasia"},{"issue":"3","key":"1448_CR128","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s11060-025-05208-5","volume":"175","author":"NS Sadagopan","year":"2025","unstructured":"Sadagopan NS, et al. NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas. J Neurooncol. 2025;175(3):979\u201391.","journal-title":"J Neurooncol"},{"issue":"Suppl 1","key":"1448_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/jcs.025742","volume":"121","author":"T Boveri","year":"2008","unstructured":"Boveri T. Concerning the origin of malignant tumours by Theodor Boveri. Translated and annotated by Henry Harris. J Cell Sci. 2008;121(Suppl 1):1\u201384.","journal-title":"J Cell Sci"},{"issue":"1","key":"1448_CR130","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41576-019-0171-x","volume":"21","author":"U Ben-David","year":"2020","unstructured":"Ben-David U, Amon A. Context is everything: aneuploidy in cancer. Nat Rev Genet. 2020;21(1):44\u201362.","journal-title":"Nat Rev Genet"},{"issue":"7438","key":"1448_CR131","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature11935","volume":"494","author":"RA Burrell","year":"2013","unstructured":"Burrell RA, et al. Replication stress links structural and numerical cancer chromosomal instability. Nature. 2013;494(7438):492\u20136.","journal-title":"Nature"},{"issue":"7252","key":"1448_CR132","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature08136","volume":"460","author":"NJ Ganem","year":"2009","unstructured":"Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009;460(7252):278\u201382.","journal-title":"Nature"},{"issue":"7689","key":"1448_CR133","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018;553(7689):467\u201372.","journal-title":"Nature"},{"key":"1448_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.10.001","author":"CD McKenney","year":"2025","unstructured":"McKenney CD, Regot S. Mechanisms of whole-genome doubling in cancer evolution. Trends Cancer. 2025. https:\/\/doi.org\/10.1016\/j.trecan.2025.10.001.","journal-title":"Trends Cancer"},{"issue":"6","key":"1448_CR135","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ccr.2012.03.044","volume":"21","author":"T Davoli","year":"2012","unstructured":"Davoli T, de Lange T. Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell. 2012;21(6):765\u201376.","journal-title":"Cancer Cell"},{"issue":"2","key":"1448_CR136","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/2159-8290.CD-13-0285","volume":"4","author":"SM Dewhurst","year":"2014","unstructured":"Dewhurst SM, et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 2014;4(2):175\u201385.","journal-title":"Cancer Discov"},{"issue":"7954","key":"1448_CR137","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41586-023-05794-2","volume":"615","author":"RA Lambuta","year":"2023","unstructured":"Lambuta RA, et al. Whole-genome doubling drives oncogenic loss of chromatin segregation. Nature. 2023;615(7954):925\u201333.","journal-title":"Nature"},{"key":"1448_CR138","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.264148","author":"RJ Wilkins","year":"2025","unstructured":"Wilkins RJ, Petermann E. Emerging roles of RNA:DNA hybrid regulation by mammalian ribonuclease H2 in replication stress and cancer. J Cell Sci. 2025. https:\/\/doi.org\/10.1242\/jcs.264148.","journal-title":"J Cell Sci"},{"issue":"32","key":"1448_CR139","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1038\/onc.2012.387","volume":"32","author":"RM Jones","year":"2013","unstructured":"Jones RM, et al. Increased replication initiation and conflicts with transcription underlie Cyclin E-induced replication stress. Oncogene. 2013;32(32):3744\u201353.","journal-title":"Oncogene"},{"issue":"4","key":"1448_CR140","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.cell.2017.07.043","volume":"170","author":"S Hamperl","year":"2017","unstructured":"Hamperl S, et al. Transcription-replication conflict orientation modulates R-loop levels and activates distinct DNA damage responses. Cell. 2017;170(4):774-786 e19.","journal-title":"Cell"},{"issue":"1","key":"1448_CR141","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.canlet.2011.08.022","volume":"313","author":"VR Gogineni","year":"2011","unstructured":"Gogineni VR, et al. Chk2-mediated G2\/M cell cycle arrest maintains radiation resistance in malignant meningioma cells. Cancer Lett. 2011;313(1):64\u201375.","journal-title":"Cancer Lett"},{"issue":"1","key":"1448_CR142","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4143\/crt.2020.1247","volume":"54","author":"KH Kim","year":"2022","unstructured":"Kim KH, et al. Increased radiosensitivity of solid tumors harboring ATM and BRCA1\/2 mutations. Cancer Res Treat. 2022;54(1):54\u201364.","journal-title":"Cancer Res Treat"},{"issue":"4","key":"1448_CR143","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1667\/RADE-22-00040.1","volume":"198","author":"SJ Bright","year":"2022","unstructured":"Bright SJ, et al. Targeted inhibition of DNA-PKcs, ATM, ATR, PARP, and Rad51 modulate response to X rays and protons. Radiat Res. 2022;198(4):336\u201346.","journal-title":"Radiat Res"},{"issue":"2","key":"1448_CR144","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5114\/fn.2014.43782","volume":"52","author":"T Csonka","year":"2014","unstructured":"Csonka T, et al. Poly(ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas. Folia Neuropathol. 2014;52(2):111\u201320.","journal-title":"Folia Neuropathol"},{"key":"1448_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-026-08899-4","author":"S Shaji","year":"2026","unstructured":"Shaji S, Na J, Hanemann CO. Targeting HDACs with dacinostat amplifies radiation-induced DNA damage via sustained phosphorylated p53 and repair inhibition in aggressive meningioma. Cell Death Dis. 2026. https:\/\/doi.org\/10.1038\/s41419-026-08899-4.","journal-title":"Cell Death Dis"},{"key":"1448_CR146","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fonc.2020.00501","volume":"10","author":"X Zhang","year":"2020","unstructured":"Zhang X, et al. Differentially expressed microRNAs in radioresistant and radiosensitive atypical meningioma: a clinical study in Chinese patients. Front Oncol. 2020;10:501.","journal-title":"Front Oncol"},{"key":"1448_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01441","volume":"10","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, et al. MicroRNA-221\/222 inhibits the radiation-induced invasiveness and promotes the radiosensitivity of malignant meningioma cells. Front Oncol. 2020;10:1441.","journal-title":"Front Oncol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01448-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-026-01448-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-026-01448-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:03:08Z","timestamp":1788850988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-026-01448-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":147,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1448"],"URL":"https:\/\/doi.org\/10.1007\/s13577-026-01448-3","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"9 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable since this article is a review.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"137"}}